Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy. [electronic resource]
Producer: 20040128Description: S17-26 p. digitalISSN:- 1537-453X
- Anastrozole
- Androstadienes -- therapeutic use
- Animals
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Aromatase Inhibitors
- Breast Neoplasms -- drug therapy
- Clinical Trials as Topic
- Enzyme Inhibitors -- therapeutic use
- Estrogen Antagonists -- therapeutic use
- Humans
- Letrozole
- Neoplasm Metastasis
- Nitriles -- therapeutic use
- Tamoxifen -- therapeutic use
- Triazoles -- therapeutic use
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.